A capsule-sponge test may help identify patients with Barrett’s esophagus who are at low risk for dysplasia or esophageal ...

Patients with low-grade dysplasia have around a one in 10 chance of developing esophageal cancer, but this risk doubles to one in five for high-grade dysplasia.

In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in ...

The highest risk of high-grade dysplasia or cancer was seen for patients with both atypia and aberrant p53 (relative risk, 135.8 relative to the low-risk group).

The low-grade version is linked with a one in 10 chance of developing esophageal cancer, while the high-grade version increases to a one in five chance. Continued monitoring of the esophagus is vital, ...

Patients with low-grade dysplasia have around a one in 10 chance of developing oesophageal cancer, but this risk doubles to one in five for high-grade dysplasia.

Identifying specific miRNA patterns in Barrett's lesions may help to detect the BE and dysplasia with more progressive potential and help to distinguish low-risk from high-risk patients.

OSWEGO – The Center for Gastroenterology & Metabolic Diseases of Oswego Health Medical Practice is now offering access to an innovative laboratory test — TissueCypher — that can help ...

A persistent low-grade fever isn’t usually cause for concern. It will typically go away on its own but may be serious for people like infants and those with immune conditions.